netFormulary
 Report : A-Z HCD items in Formulary 13/06/2021 11:55:07
[Back]
 
Section Status Black Triangle Name
08.01.05 Formulary Black Triangle Abemaciclib Verzenios®
08.02.03 Formulary Black Triangle Avelumab Bavencio®
13.05.03 Formulary Black Triangle Baricitinib Olumiant®
10.01.03 Formulary Black Triangle Belimumab 
03.04.02 Formulary Black Triangle Benralizumab Fasenra®
08.01.05 Formulary Black Triangle Bosutinib Bosulif®
08.01.05 Formulary Black Triangle Brigatinib Alunbrig®
10.01.03 Restricted Use Black Triangle Brodalumab Kyntheum®
11.08.02 Formulary Black Triangle Brolucizumab Beovu®
08.02.03 Formulary Black Triangle Caplacizumab Cablivi®
08.01.05 Formulary Black Triangle Carfilzomib Kyprolis ®
08.01.05 Formulary Black Triangle Cemiplimab Libtayo®
08.01.05 Formulary Black Triangle Dacomitinib Vizimpro®
08.01.05 Formulary Black Triangle Daratumumab  Darzalex®
08.03.04.02 Formulary Black Triangle Darolutamide Nubeqa®
06.01.02.03 Formulary Black Triangle Dulaglutide Trulicity®
08.01.05 Formulary Black Triangle Durvalumab Imfinzi®
08.01.05 Formulary Black Triangle Encorafenib  Braftovi®
08.01.05 Formulary Black Triangle Entrectinib Rozlytrek®
04.07.04.02 Formulary Black Triangle Erenumab Aimovig®
06.01.02.03 Formulary Black Triangle Ertugliflozin Steglatro®
10.01.03 Formulary Black Triangle Filgotinib Jyseleca®
04.07.04.02 Formulary Black Triangle Fremanezumab Ajovy®
04.07.04.02 Formulary Black Triangle Galcanezumab Emgality®
08.01.05 Formulary Black Triangle Gilteritinib Xospata®
05.03.03.02 Restricted Use Black Triangle Glecaprevir - pibrentasvir Maviret®
08.01.05 Formulary Black Triangle Ibrutinib Imbruvica ®
13.08.01 Restricted Use Black Triangle Ingenol mebutate Picato®
08.02.03 Formulary Black Triangle Inotuzumab ozogamicin Besponsa®
06.01.01.01 Formulary Black Triangle Insulin Aspart Fiasp®
09.01.01.02 Formulary Black Triangle Iron Isomaltoside Monofer®
08.02.03 Formulary Black Triangle Isatuximab Sarclisa®
03.04.03 Formulary Black Triangle Lanadelumab Takhzyro®
08.02.04 Formulary Black Triangle Lenalidomide Revlimid®
08.01.05 Formulary Black Triangle Lenvatinib Kisplyx®
08.01.05 Formulary Black Triangle Lorlatinib Lorviqua®
03.07 Formulary Black Triangle Lumacaftor with ivacaftor Orkambi®
08.03.04.03 Formulary Black Triangle Lutetium (177Lu) oxodotreotide 
01.06.06 Formulary Black Triangle Naldemedine Rizmoic®
08.03.04.01 Formulary Black Triangle Neratinib Nerlynx®
08.02.03 Formulary Black Triangle Nivolumab Opdivo®
10.02 Formulary Black Triangle Nusinersen® Spinraza
08.02.03 Formulary Black Triangle Ocrelizumab  Ocrevus®
08.01.05 Formulary Black Triangle Olaratumab Lartruvo®
08.01.05 Formulary Black Triangle Osimertinib  Tagrisso ®
08.01.05 Formulary Black Triangle Palbociclib Ibrance®
09.02.01.01 Formulary Black Triangle Patiromer calcium Veltassa®
08.02.03 Formulary Black Triangle Polatuzumab vedotin Polivy®
08.01.05 Formulary Black Triangle Ribociclib Kisqali®
13.05.03 Formulary Black Triangle Risankizumab Skyrizi®
02.08.02 Formulary Black Triangle Rivaroxaban Xarelto®
02.08.02 Formulary Black Triangle Rivaroxaban Xarelto®
08.02.04 Formulary Black Triangle Rucaparib Rubraca®
06.01.02.03 Formulary Black Triangle Semaglutide Ozempic®
08.02.04 Formulary Black Triangle Siponimod Mayzent®
09.02.01.01 Formulary Black Triangle Sodium zirconium cyclosilicate Lokelma®
08.01.05 Formulary Black Triangle Talimogene laherparepvec Imlygic®
13.05.03 Formulary Black Triangle Tildrakizumab Ilumetri®
01.05.03 Formulary Black Triangle Tofacitinib Xeljanz®
10.01.03 Formulary Black Triangle Tofacitinib  Xeljanz ®
10.01.03 Formulary Black Triangle Upadacitinib Rinvoq®
08.01.05 Formulary Black Triangle Venetoclax Venclyxto®
South Staffordshire Joint Formulary